page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Tolmetin (Tolectin, Tolectin DS)

Category:

  • Analgesic

Description:

  • Nonsteroidal anti-inflammatory (NSAID) drug

Indications:

  • Mild to moderate pain, osteoarthritis

  • Rheumatoid arthritis, ankylosing spondylitis

Contraindications:

  • Asthma, severe renal disease

  • Severe hepatic disease, ulcer disease

Precautions:

  • Pregnancy category B (D near term), small amounts excreted in breast milk, compatible with breast feeding

  • Children, bleeding disorders

  • GI disorders, cardiac disorders

  • Hypersensitivity to other anti-inflammatory agents, peptic ulcer disease

Adverse Reactions (Side Effects):

  • CNS: anxiety, confusion, depression, dizziness, drowsiness, fatigue, insomnia, tremors

  • CV: dysrhythmias, hypertension, palpitations, peripheral edema, tachycardia

  • EENT: blurred vision, hearing loss, tinnitus

  • GI: anorexia, bleeding, cholestatic hepatitis, constipation, cramps, diarrhea, jaundice, nausea, peptic ulcer, perforation, ulceration, vomiting

  • GU: azotemia, dysuria, hematuria, nephrotoxicity, oliguria, pseudoproteinuria

  • HEME: blood dyscrasias

  • SKIN: pruritus, purpura, rash, sweating

Dosage:

Administered orally

  • Adult:   PO 400mg 3-4 times daily, not to exceed 2g daily

  • Child >2 years: PO 15-30 mg/kg/day in 3 or 4 divided doses

 Drug interactions:

  • Methotrexate: potentially increase methotrexate concentrations and toxicity

  • Potassium sparing diuretics: potential for acute renal failure (i.e., indomethacin and triamterene)

  • Cyclosporine: Other NSAIDs increase cyclosporine concentrations

  • Angiotensin-converting enzyme (ACE) inhibitors: inhibits the antihypertensive effects of ACE inhibitors

  • Beta-blockers: reduced hypotensive effects of beta-blockers

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site